NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN, ETC
申请人:Rhizen Pharmaceuticals SA
公开号:US20150057309A1
公开(公告)日:2015-02-26
The present invention provides compounds useful as c-Met protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of c-Met kinase mediated disease or disorders with them.
本发明提供了作为c-Met蛋白激酶调节剂有用的化合物,以及制备它们的方法,含有它们的药物组合物,以及使用它们进行治疗、预防和/或改善c-Met激酶介导的疾病或疾病的方法。
[EN] NOVEL 3,5-DISUBSTITUED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN KINASES<br/>[FR] NOUVEAUX COMPOSÉS 3,5-DISUBSTITUÉS-3H-IMIDAZO[4,5-B]PYRIDINES ET 3,5-DISUBSTITUÉS-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDINES EN TANT QUE MODULATEURS DES PROTÉINES KINASES C-MET
申请人:RHIZEN PHARMACEUTICALS SA
公开号:WO2013144737A2
公开(公告)日:2013-10-03
The present invention provides compounds useful as C-met protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of C-met kinase mediated diseases or disorders with them.